Frederic Caux, PhD
SESSIONS
S040 Late-Breaking Research: Session 2
Mar 8, 2025
•
1:00 PM - 4:00 PM
•
Chapin Theater - Level III
F047 Autoimmune Blistering Diseases: What's New?
Mar 8, 2025
•
3:30 PM - 5:30 PM
•
W307A
DISCLOSURES
arGEN-X – Advisory Board(Honoraria), Investigator(Fees); Boehringer Ingelheim – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Speaker(Honoraria); Regeneron – Investigator(Fees); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria);